Back
CorMedix, Inc. Stock Price Chart
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
20
CRMD
CorMedix, Inc.
Last Price:
$6.77
Seasonality Move:
22.39%
7 Day Trial
ALL ACCESS PASS
$
7
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRMD is experiencing selling pressure, which indicates risk of future bearish movement.
CorMedix, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.68 | Sell |
| 20-day SMA: | 10.28 | Sell |
| 50-day SMA: | 10.51 | Sell |
| 200-day SMA: | 11.22 | Sell |
| 8-day EMA: | 7.87 | Sell |
| 20-day EMA: | 9.36 | Sell |
| 50-day EMA: | 10.22 | Sell |
| 200-day EMA: | 7.65 | Sell |
CorMedix, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.15 | Sell |
| Relative Strength Index (14 RSI): | 22.61 | Sell |
| Chaikin Money Flow: | -2703139 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.39 - 12.67) | Sell |
| Bollinger Bands (100): | (9.64 - 12.78) | Sell |
CorMedix, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for CorMedix, Inc. Stock
Is CorMedix, Inc. Stock a Buy?
-
CorMedix, Inc. share price is 6.78 while CRMD 8-day simple moving average is 7.68, which is a Sell signal.
-
The stock price of CRMD is 6.78 while CorMedix, Inc. 20-day SMA is 10.28, which makes it a Sell.
-
CorMedix, Inc. 50-day simple moving average is 10.51 while CRMD share price is 6.78, making it a Sell technically.
-
CRMD stock price is 6.78 and CorMedix, Inc. 200-day simple moving average is 11.22, creating a Sell signal.
CRMD Technical Analysis vs Fundamental Analysis
Sell
20
CorMedix, Inc. (CRMD)
is a Sell
Is CorMedix, Inc. a Buy or a Sell?
-
CorMedix, Inc. stock is rated a SellThe current CorMedix, Inc. [CRMD] share price is $6.78. The Score for CRMD is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
CorMedix, Inc. Stock Info
Market Cap:
534.2M
Price in USD:
6.78
Share Volume:
2.9M
CorMedix, Inc. 52-Week Range
52-Week High:
17.43
52-Week Low:
5.60
Sell
20
CorMedix, Inc. (CRMD)
is a Sell
CorMedix, Inc. Share Price Forecast
-
What is the CorMedix, Inc. stock price today?The CorMedix, Inc. stock price is 6.78 USD today.
-
Will CRMD stock go up or go down?CorMedix, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is CorMedix, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, CorMedix, Inc. is overvalued.
Is CorMedix, Inc. Stock a Buy?
-
CorMedix, Inc. share price is 6.78 while CRMD 8-day exponential moving average is 7.87, which is a Sell signal.
-
The stock price of CRMD is 6.78 while CorMedix, Inc. 20-day EMA is 9.36, which makes it a Sell.
-
CorMedix, Inc. 50-day exponential moving average is 10.22 while CRMD share price is 6.78, making it a Sell technically.
-
CRMD stock price is 6.78 and CorMedix, Inc. 200-day simple moving average is 7.65, creating a Sell signal.
Fundamental Analysis of CorMedix, Inc.
Is CorMedix, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.28 per share, and a decrease next year of $0.10 per share.
Technical Analysis of CorMedix, Inc.
Should I short CorMedix, Inc. stock?
-
CRMD Moving Average Covergence Divergence (MACD) indicator is -1.15, suggesting CorMedix, Inc. is a Sell
-
CorMedix, Inc. Relative Strength Index (RSI) is 22.61, which suggest CorMedix, Inc. is oversold
-
The Bollinger Bands (25) for CorMedix, Inc. is (8.39 - 12.67), which suggest CorMedix, Inc. is a Sell
-
The Bollinger Bands (100) for CorMedix, Inc. is (9.64 - 12.78), which suggest CorMedix, Inc. is a Sell
* CorMedix, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.